Skip to main content

Month: June 2025

21Shares welcomes FCA’s decision to open retail access to Crypto ETNs

The decision paves the way for broader digital asset adoption in the UK London, 6 June 2025 – 21Shares, one of the world’s leading issuers of cryptocurrency exchange-traded products (ETPs) and the first to list crypto ETNs on the London Stock Exchange (LSE), welcomes the Financial Conduct Authority’s (FCA) announcement today proposing to lift the ban on offering crypto exchange-traded notes (cETNs) to UK retail investors. The proposal aims to support innovation and competitiveness in the UK’s digital asset sector while ensuring robust investor protection. Crypto ETNs are already widely accessible to retail investors in other major jurisdictions across Europe, and this change would bring the UK into alignment with global best practice. “This is a landmark moment for the UK digital asset market,” said Russell Barlow, CEO of 21Shares....

Continue reading

Fury Upsizes Financing to C$3.08 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 06, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) announces that the proposed private placement offering announced June 5, 2025 has been increased from C$2,500,000 to C$3,080,000. Fury now intends to privately place with a small group of accredited and institutional investors in Canada a total of 4,000,000 flow-through common shares (the “Shares”) of the Company, at a price of C$0.77 per Share for total gross proceeds of C$3,080,000 (the “Offering”). This offering figure could increase by up to approximately 15.4% if a strategic investor elects to exercise its pre-emptive participation rights disclosed in a May 27, 2025 news release. The Offering is expected to...

Continue reading

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 data support vepdegestrant as a potential treatment option in patients with ESR1m ER+/HER2- advanced or metastatic breast cancer – NEW HAVEN, Conn., June 06, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) with its partner Pfizer Inc. (NYSE: PFE), for vepdegestrant for the treatment of patients with ER-positive (ER+)/human epidermal growth factor receptor 2 (HER2)-negative (ER+/HER2-) ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based...

Continue reading

G-III Apparel Group, Ltd. Reports First Quarter Fiscal 2026 Results

Net Income Per Diluted Share of $0.17 for the First Quarter Compared to $0.12 Last Year and Non-GAAP Net Income Per Diluted Share of $0.19 for the First Quarter Compared to $0.12 Last Year, Both Exceeding Guidance Net Sales of $583.6 Million for the First Quarter Compared to $609.7 Million Last Year Repurchases of $19.7 Million or 807,437 Shares in the First Quarter Reaffirms Net Sales Guidance for Fiscal 2026NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) — G-III Apparel Group, Ltd. (NasdaqGS: GIII) (“G-III” or the “Company”) today reported results for the first quarter of fiscal 2026, ended April 30, 2025. Morris Goldfarb, G-III’s Chairman and Chief Executive Officer, said, “G-III delivered solid first quarter results, marked by earnings that exceeded the high end of guidance. Our performance was fueled by double-digit growth of...

Continue reading

Form 8.3 – [MARLOWE PLC – 05 06 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MARLOWE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

ABM Reports Fiscal Second Quarter 2025 Results

Revenue up 4.6% to $2.1 billion, with organic growth contributing 3.8% Business & Industry and Manufacturing & Distribution return to organic revenue growth Net income of $42.2 million and earnings per diluted share of $0.67, versus $43.8 million and $0.69 in the prior year, respectively Adjusted net income of $54.1 million and adjusted earnings per diluted share of $0.86, versus $52.3 million, or $0.82 in the prior year, respectively Adjusted EBITDA of $125.9 million versus $121.0 million in the prior year Reaffirms full year adjusted EPS outlook of $3.65 to $3.80 (1)NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for fiscal second quarter ended April 30, 2025. “ABM’s second quarter performance was highlighted by a return to...

Continue reading

Ferrellgas Partners, L.P. Reports Third Quarter Fiscal Year 2025 Results

LIBERTY, Mo., June 06, 2025 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”) today reported financial results for its 2025 third fiscal quarter ended April 30, 2025. Tamria Zertuche, President and Chief Executive Officer, commented, “We are very pleased to have delivered strong third quarter sales growth of 9%, which translated into solid gross profit, and net earnings growth of 12%. This growth was driven by our strong field performance in inclement weather and residential market growth.” Ms. Zertuche continued, “The Company has been named once again by Newsweek as one of the Most Trustworthy Companies in America. The dedication and commitment our employee-owners make to our customers is a key driver in our growth. We are grateful for the outstanding efforts of our employees who continue...

Continue reading

Form 8.3 – [GLOBALDATA PLC – 05 06 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GLOBALDATA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [CRANEWARE PLC – 05 06 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CRANEWARE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Black Gold Expands Market Presence with Triple Listings

BGX Unlocks Global Exposure with Listings on CSE, OTCQB, and Frankfurt VANCOUVER, B.C., June 06, 2025 (GLOBE NEWSWIRE) — Black Gold Exploration Corp. (the “Company” or “BGX”) (CSE: BGX) (OTCQB: BGXCF) (FRA: BLGX) announces that its common shares are now trading under the symbol “BGXCF” on the OTCQB board of OTC Markets, a US trading platform that is operated by the OTC Markets Group in New York (the “OTC Listing”). The Company’s common shares will continue to trade on the Company’s primary market, the Canadian Securities Exchange, under the symbol “BGX” as well as on the Frankfurt Stock Exchange under the symbol “BLGX”. This strategic expansion enhances BGX’s visibility, trading accessibility, and investor reach across North America and Europe, opening the door to a broader base of shareholders who the Company believes will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.